scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00384-004-0592-6 |
P698 | PubMed publication ID | 15103490 |
P50 | author | Volker Schumpelick | Q2531281 |
P2093 | author name string | Elke Roeb | |
Siegfried Matern | |||
Marlies Arndt | |||
Bettina Jansen | |||
P2860 | cites work | Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties | Q28618856 |
Human progelatinase A can be activated by matrilysin | Q28618916 | ||
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 | ||
How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist | Q31114517 | ||
Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis | Q34013787 | ||
Matrix metalloproteinases in tumor invasion: role for cell migration | Q34657461 | ||
Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics | Q35000708 | ||
Matrix metalloproteinases in colorectal cancer | Q35008599 | ||
Matrix metalloproteinases in cancer. | Q35015124 | ||
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers | Q35356264 | ||
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer | Q35586378 | ||
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. | Q35782300 | ||
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas | Q36617718 | ||
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas | Q36622242 | ||
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. | Q36836819 | ||
Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer | Q38478473 | ||
Collagenases (second of three parts). | Q39901828 | ||
Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions | Q41053282 | ||
Matrix metalloproteinases. Novel targets for directed cancer therapy | Q41597461 | ||
Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma | Q42279639 | ||
Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis | Q43903188 | ||
Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer | Q48561841 | ||
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. | Q53471613 | ||
Processing of tumour necrosis factor-α precursor by metalloproteinases | Q59059630 | ||
TIMP expression in toxic and cholestatic liver injury in rat | Q62658920 | ||
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo | Q72132819 | ||
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis | Q72145804 | ||
Expression of matrix metalloproteinase-1 in human colorectal carcinoma | Q73009012 | ||
MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer | Q73743021 | ||
An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist | Q74270190 | ||
Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis | Q74534951 | ||
Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features | Q77340404 | ||
Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9 | Q77357082 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 518-524 | |
P577 | publication date | 2004-04-22 | |
P1433 | published in | International Journal of Colorectal Disease | Q15758189 |
P1476 | title | Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas | |
P478 | volume | 19 |
Q37026757 | Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions |
Q80080223 | Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer |
Q35104008 | Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas |
Q35206743 | Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis |
Q53340431 | Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential? |
Q49403899 | Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma |
Q89474204 | Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer |
Q37464728 | ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. |
Q36385822 | Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis |
Q42259293 | Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration |
Q37687427 | Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions |
Q79363986 | Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation |
Q38897558 | Microcystin-LR promotes migration and invasion of colorectal cancer through matrix metalloproteinase-13 up-regulation |
Q33755325 | Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice |
Q59101042 | Overexpression of MMP13 is associated with clinical outcomes and poor prognosis in oral squamous cell carcinoma |
Q35948104 | PDEF is a negative regulator of colon cancer cell growth and migration |
Q52873874 | Protease probes that enable excimer signaling upon scission. |
Q35223677 | Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-α and bradykinin in human colonic myofibroblasts |
Q37081755 | SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. |
Q42367521 | Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer. |
Q43722831 | The association of matrix metalloproteinase-1 genetic polymorphism (-1607 1G>2G) with colorectal cancer: a meta-analysis |
Q36610051 | The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer |
Q39380237 | The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells. |
Q49263979 | The role of cadherin-11 in microcystin-LR-induced migration and invasion in colorectal carcinoma cells |
Q90383878 | Xanthones from the Bark of Garcinia xanthochymus and the Mechanism of Induced Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells via the Mitochondrial Pathway |
Search more.